Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12345 Next »
Viewing Page 1 of 21 | Showing Results 1 - 5 of 101

Phase 1b/II Trial of Carfilzomib with Irinotecan in Irinotecan-Sensitive Malignancies (Phase Ib) and Small Cell Lung Cancer Patients (Phase II) Who Have Progressed on Prior Platinum-based Chemotherapy (Onyx IST Reference Number: CAR-IST-553)

The purpose of this study is to determine a well-tolerated dose of Carfilzomib in combination with Irinotecan in subjects with relapsed small and...

Rachel Sanborn, M.D.
  • Oncology and Hematology Care Eastside
  • Oncology and Hematology Care Westside

An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and Intensive Loperamide Prophylaxis

This is an open-label, Phase 2 study that will investigate the incidence of diarrhea in HER2+ breast cancer patients receiving neratinib with...

Alison Conlin, M.D.
  • Oncology and Hematology Care Eastside
  • Oncology and Hematology Care Southeast
  • Oncology and Hematology Care Westside

Study of Systemic and Bone Marrow Myeloid Derived Suppressor Cells (MDSC) and the tumor microenvironment in Patients with Myelodysplastic Syndromes (MDS)

This prospective biospecimen collection study will enroll patients undergoing peripheral blood testing and or bone marrow biopsy for known or...

John Godwin, M.D.
  • Oncology and Hematology Care Eastside
  • Oncology and Hematology Care Newberg
  • Oncology and Hematology Care Southeast
  • Oncology and Hematology Care Westside

A Phase 1, First in Human, Dose Escalation Study of MGD006, a CD123 x CD3 Dual Affinity Re-Targeting (DART®) Bi-Specific Antibody Based Molecule, in Patients With Relapsed or Refractory AML or Intermediate-2/High Risk MDS

The primary goal of this Phase 1, dose-escalation study, is to determine the maximum tolerated dose level of MGD006 in patients with AML and MDS...

John Godwin, M.D.
  • Oncology and Hematology Care Eastside

HVP BEST-CLI-Best Endovascular Versus Best Surgical Therapy in Patients With Critical Limb Ischemia

This study will compare the effectiveness of best available surgical treatment with best available endovascular treatment in adults with critical...

Ethan Korngold MD
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center
« Previous 12345 Next »
Viewing Page 1 of 21 | Showing Results 1 - 5 of 101